Mazen Hammad

Vice President

2023 - Current

Early-stage healthcare venture capital firm with $1.5B+ AUM and 60+ portfolio companies, including Alma, Ambience, Brightline, CareBridge, Cortica, DispatchHealth, Equip, Garner, Synapticure and Truepill, among others.

Associate

2021 - 2023

Senior M&A Analyst

2019 - 2021

Fortune-5 M&A experience in healthcare technology, value-based care delivery and clinicogenomics • $13B+ acquisition of Change Healthcare (Nasdaq: CHNG) • $1B+ acquisition of scaled multi-specialty medical group • $1B+ venture funding round for digital health start-up

Portfolio Manager

2017 - 2018

$25M+ Growth Equities Fund - Technology, Media, Telecommunications

President

2017 - 2018

Vice President & Treasurer

2017 - 2018

Investment Banking Summer Analyst

2018 - 2018

Technology M&A